Based on the essential role played by small GTPases (and their regulators) during angiogenesis, including the maintenance of endothelial integrity, as well as in cancer progression and metastasis [86,94,95], we focused our attention on the newly identified NOVA2 target RapGEF6. Here, RAPGEF6 is linked to cancer.